Amprion, a global leader advancing diagnosis of neurodegenerative disorders through seed amplification testing, and Modality.AI, a leader in AI-enabled multimodal clinical assessments, today announced ...
Collaboration combines molecular biomarkers with AI-enabled digital assessments to support more precise characterization of neurodegenerative disease Amprion, a global leader advancing diagnosis of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results